SWEET‑STAb: A new strategy to fight solid tumors using T lymphocytes

Aim of the project
SWEET‑STAb will develop modified T‑cell therapies capable of recognizing specific signals present in solid tumors, improving the specificity and effectiveness of treatment and offering new therapeutic options for patients with lung or pancreatic cancer.

  • Dr. Daniel Salas
  • Dr. Daniel Salas
  • Research centre: Centro Nacional Investigaciones Oncológicas (CNIO)
  • Year: 2025
  • Profile in Spanish: Coming soon